Published in Health Business Week, December 8th, 2006
These are the findings of a Cleveland Clinic-led study that was published in the Nov. 28 issue of the European Heart Journal.
The Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE II), a randomized, multicenter pilot study, compared the safety and effectiveness of subcutaneous enoxaparin (a low molecular weight version of the blood thinner...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.